Singapore markets closed

Novartis AG (NOVN.SW)

Swiss - Swiss Delayed price. Currency in CHF
Add to watchlist
97.45+0.52 (+0.54%)
At close: 05:30PM CEST
Show:
Balance sheet
Cash flow
Annual

Income statement

Currency in USD. All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
Total revenue
48,860,000
46,660,000
43,461,000
43,974,000
49,898,000
Cost of revenue
12,408,000
12,472,000
11,582,000
11,735,000
15,121,000
Gross profit
36,452,000
34,188,000
31,879,000
32,239,000
34,777,000
Operating expenses
Research development
11,280,000
11,371,000
9,172,000
8,641,000
8,980,000
Selling general and administrative
12,466,000
12,517,000
12,193,000
12,827,000
14,197,000
Total operating expenses
24,721,000
24,419,000
23,933,000
22,183,000
24,625,000
Operating income or loss
11,731,000
9,769,000
7,946,000
10,056,000
10,152,000
Interest expense
906,000
855,000
800,000
787,000
869,000
Total other income/expenses net
-254,000
-227,000
-195,000
15,268,000
538,000
Income before tax
10,899,000
9,123,000
7,177,000
24,530,000
9,878,000
Income tax expense
814,000
551,000
1,128,000
1,625,000
1,807,000
Income from continuing operations
10,085,000
8,572,000
6,049,000
22,905,000
8,071,000
Net income
16,175,000
14,850,000
6,955,000
24,021,000
8,072,000
Net income available to common shareholders
16,175,000
14,850,000
6,955,000
24,021,000
8,072,000
Basic EPS
3.74
7.15
3.19
10.71
3.55
Diluted EPS
3.73
7.10
3.17
10.63
3.52
Basic average shares
2,097,750
2,076,794
2,181,000
2,243,000
2,277,000
Diluted average shares
2,113,000
2,092,000
2,197,000
2,260,000
2,296,000